Mycoral-M Tablet

By Mycoral

Rx

10 Tablet in a Strip

Composition icon

Composition

Mycophenolate mofetil(500mg)

Manufacturer - Wockhardt Ltd icon

Manufacturer - Wockhardt Ltd

Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India

Expires on or after icon

Expires on or after

August, 2025

About Mycoral-M Tablet

Mycoral-M Tablet is classified as an immunosuppressant medication, which is typically used in combination with other drugs to prevent the rejection of transplanted organs like kidneys, hearts, or livers. The purpose of Mycoral-M Tablet is to suppress the body's immune system so that it does not attack the newly transplanted organ. The dosage and frequency of taking Mycoral-M Tablet depend on the specific type of transplant received, and it is crucial to strictly follow the doctor's instructions. It is recommended to take the tablet on an empty stomach, at least an hour before or two hours after a meal, unless otherwise directed by the doctor. The tablet should be swallowed whole without crushing, chewing, or breaking it for optimal effectiveness.

Consistent and regular intake of Mycoral-M Tablet is essential to derive maximum benefits and prevent rejection of the transplanted organ. Even if the individual feels well, it is important to continue taking the medication as prescribed by the doctor for the duration needed to avoid rejection. However, it is vital to be aware of potential side effects associated with Mycoral-M Tablet, such as nausea, vomiting, diarrhea, stomach pain, headache, high blood pressure, and changes in white blood cell count. Due to its immunosuppressant nature, individuals taking this medication may be more susceptible to infections and have an increased risk of developing certain cancers.

It is crucial to note that Mycoral-M Tablet can lead to birth defects and abortion; therefore, it should not be taken by pregnant women, those planning to conceive, or breastfeeding mothers. Prior consultation with a doctor is necessary if any signs of infection, unexpected bruising, or bleeding occur before initiating the medication. Additionally, informing the healthcare team about all other medications being taken is important as they may interact with or be affected by Mycoral-M Tablet. Regular monitoring through blood tests to track changes in blood cell count, sugar levels, and cholesterol is part of the standard procedure while on this medication. By adhering to these guidelines and precautions, individuals can effectively manage their post-transplant care with Mycoral-M Tablet to prevent organ rejection.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

775.64

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 07-Oct-2024